Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010-11.

Emerging infectious diseases - 1 Nov 2011

Sleeman Katrina, Sheu Tiffany G, Moore Zack, Kilpatrick Susan, Garg Shikha, Fry Alicia M, Gubareva Larisa V

Abstract excerpt

Oseltamivir is 1 of 2 antiviral medications available for the treatment of influenza B virus infections. We describe and characterize a cluster of influenza B viruses circulating in North Carolina with a mutation in the neuraminidase active site that may reduce susceptibility to oseltamivir and the investigational drug peramivir but not to zanamivir.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclopentanes
Share to Guanidines
Share to Hemagglutinin Glycoproteins, Influenza Virus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Influenza B virus

Share to Influenza, Human

Share to Neuraminidase

Share to North Carolina

Share to Oseltamivir

Source

Open in PubMed Open full text

Identifiers

PMID: 22099093
DOI: 10.3201/eid1711.110787
PMCID: PMC3310577

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010-11.PMID 22099093Read ↗

Characterization of influenza B viruses with reduced susceptibility to influenza neuraminidase inhibitorsSemantic proximity Read ↗

Recovery of Influenza B Virus with the H273Y Point Mutation in the Neuraminidase Active Site from a Human PatientSemantic proximity Read ↗

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.Semantic proximity Read ↗

A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.Semantic proximity Read ↗

Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile.Semantic proximity Read ↗

Oseltamivir resistance in an influenza A (H3N2) virus isolated from an immunocompromised patient during the 2014-2015 influenza season in Alberta, Canada.Semantic proximity Read ↗

The current strategies of optimization of oseltamivir against mutant neuraminidases of influenza A：A review.Semantic proximity Read ↗

Global Epidemic Trend Analysis of Influenza Type B Drug Resistance Sites From 2006 To 2018Semantic proximity Read ↗

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014Semantic proximity Read ↗

Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea.Semantic proximity Read ↗

Detection and management of antiviral resistance for influenza virusesSemantic proximity Read ↗

Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of KoreaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.